Lithium monotherapy-induced tardive dyskinesia

Tardive dyskinesia is a movement disorder that develops during the course of long-term treatment with neuroleptic agents and is characterized primarily by choreiform, athetotic or rhythmic involuntary movements of mouth, face, trunk and limbs (Kane, 1995, Fountoulakis et al., 2006). Its onset is typically delayed, with symptoms first appearing only after years of treatment. It is reportedly affecting about 20-30% of patients treated with long-term neuroleptic medications, with 5% of them developing TD each year they remain on these drugs.
Source: Journal of Affective Disorders - Category: Neurology Authors: Source Type: research